TaiwanJ Pharmaceuticals Co., Ltd.

NT$6.04As of Sun 8 Nov 2026, 12:00 UTC
TPEx:6549Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (11.43%)
Div yield —
ROE (24.99%)
Biotechnology
Beta (5Y) (1.11)
PE TTM —
TSR TTM (23.06%)
Mkt cap NT$483.9M
ROIC (343.77%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$6.69
10.84%
(69.43%)
Hold 10|10|3|11|0
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.10
0.11
0.11
0.11
5.79%
7.87%
9.07%
13.61%
RevenueNT$M
48.36
49.57
52.05
55.05
11.19%
15.21%
18.57%
19.96%
Peers (US$14.62M)
Cap (US$)
PE
14.53M
112.3x
Capital
TTM
5Y
10Y
Leveragex
0.119
0.106
0.090
EBIT/Intx
0.220
0.144
0.137
Own earn%
(60.33)
115.59
113.01
Sh yield%
31.07
43.00
41.44
Owners
Insiders/Inst%
1.04
79.73
Short interest%
0.95
SBC / revenue%
4.38
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–11
$1 testx
0.7
Incr. ROIC%
29